AQR Arbitrage LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 47 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2023$862,628
+1.0%
79,873
-0.2%
0.04%
+42.3%
Q1 2023$854,389
-77.1%
79,999
-78.0%
0.03%
-72.9%
Q4 2022$3,738,055
+2.0%
362,9180.0%0.10%
+18.5%
Q3 2022$3,665,000
+0.7%
362,9180.0%0.08%
-1.2%
Q2 2022$3,640,000
+0.3%
362,9180.0%0.08%
-13.7%
Q1 2022$3,629,000
+10.4%
362,918
+9.5%
0.10%
+13.1%
Q4 2021$3,286,000331,5350.08%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2022
NameSharesValueWeighting ↓
Beryl Capital Management LLC 542,376$5,570,3642.24%
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,287,5001.00%
Lynwood Capital Management Inc. 59,615$6130.74%
Sage Rock Capital Management LP 183,998$1,889,7150.59%
HGC Investment Management Inc. 1,000,000$10,1800.44%
GRITSTONE ASSET MANAGEMENT LLC 34,026$349,4570.44%
MMCAP International Inc. SPC 370,000$3,796,2000.38%
METEORA CAPITAL, LLC 168,532$1,730,8740.37%
Exos TFP Holdings LLC 125,771$1,290,4100.36%
Bulldog Investors, LLP 90,650$931,4290.28%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders